Company Number: 14338676

Analysis Date: 2025-07-20 12:35 UTC

1. Credit Opinion: APPROVE with monitoring. Ssyd61 Ltd is a micro private limited company in the general medical practice sector showing a significant positive turnaround in its financial position in the latest year. The company moved from a net current liability and negligible net assets to a strong net current asset position (£62,385) and net assets of £65,895. This indicates improved operational cash management and balance sheet strength. Given the positive trend and absence of overdue filings, the company appears creditworthy for modest lending or trade credit, but as a young entity (incorporated 2022), ongoing monitoring is advised.

2. Financial Strength: The balance sheet shows very low fixed assets (£3,510) reflecting a service-based business with limited capital expenditure. The key improvement is in current assets, which rose sharply from £36,920 to £134,994, while current liabilities increased moderately from £38,015 to £72,609. This results in a healthy net working capital of £62,385 and net assets of £65,895, indicating that the company is well-capitalized relative to its size. Shareholders’ funds reflect retained earnings growth from £65 to £65,895, showing profitability or capital injections over the year.

3. Cash Flow Assessment: The strong net current assets suggest adequate liquidity to meet short-term obligations comfortably. The company’s working capital position improved from negative to positive, which is critical for operational resilience. While detailed cash flow statements are not provided, the growth in current assets versus liabilities implies positive cash generation or capital infusion. The company’s micro status and small employee base (2 average employees) likely help maintain low overheads and cash burn.

4. Monitoring Points:

   • Continued maintenance of positive net current assets and liquidity ratios.
   • Consistency in profitability and cash flow generation in future accounts.
   • Any significant increases in current liabilities or deterioration in working capital.
   • Business continuity risks as a young company; monitor operational performance and market conditions.
   • Director conduct and compliance with filing deadlines (currently up to date).